{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:44:58Z","timestamp":1794296698028,"version":"4.9.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Prostate cancer metastasis to the rectal mucosa, a relatively rare metastatic site, leads to a higher clinical stage and poorer prognosis. A 65-year-old man with prostate cancer underwent <jats:sup>18<\/jats:sup>F\u2013prostate-specific membrane antigen (PSMA) PET\/CT for staging. Intense <jats:sup>18<\/jats:sup>F-PSMA uptake occurred at the primary lesion, bladder, adjacent seminal vesicle, and rectum. PET\/CT imaging revealed increased homogeneous round activity of the rectal wall. The final diagnosis was prostate cancer metastasis to the rectal mucosa. This case suggested that <jats:sup>18<\/jats:sup>F-PSMA PET\/CT may assist in locating rare metastases of prostate cancer, with potential value for early staging.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004560","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T14:27:28Z","timestamp":1675348048000},"page":"354-355","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Asymptomatic Prostate Cancer Metastasis in Rectal Mucosa Revealed by 18F-PSMA-1007 PET\/CT"],"prefix":"10.1097","volume":"48","author":[{"given":"Shu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuena","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1,14]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMra1701695","article-title":"Metastatic prostate cancer","volume":"378","year":"2018","journal-title":"N Engl J Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","year":"2017","journal-title":"JAMA"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ijrobp.2020.04.025","article-title":"Increased frequency of mesorectal and perirectal LN involvement in T4 prostate cancers","volume":"107","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.amjms.2020.08.006","article-title":"Prostate cancer invading the rectum misdiagnosed as rectal cancer","volume":"361","year":"2021","journal-title":"Am J Med Sci"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.120.246363","article-title":"Diagnostic accuracy of 18F-PSMA-1007 PET\/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence","volume":"62","year":"2021","journal-title":"J Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1097\/RLU.0000000000004234","article-title":"Vas deferens and inguinal canal metastasis of prostate cancer revealed by 68Ga\u2013prostate-specific membrane antigen PET\/CT","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00259-020-04934-4","article-title":"Consensus statements on PSMA PET\/CT response assessment criteria in prostate cancer","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:05:21Z","timestamp":1750536321000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,14]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004560","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,14]]}}}